Technology has upended the old ways of running clinical trials. Fast forwarded by the pandemic and the need for trial continuity amidst widespread disruption of the bricks and mortar trial sites, decentralised clinical trials (DCTs) are now increasingly being mainstreamed as part of the drug development process. With the outlook for the pandemic still uncertain and the risk of new variants emerging, the trend towards virtualisation of clinical trials and the resilience they enable looks set to continue. 

A vital part of ensuring the success of DCT initiatives will be to ensure that trials are built around the needs of trial participants. Patient-centricity is about much more than reducing travel time and embracing diversity and inclusivity. A truly patient-focused trial is about creating a personalised experience for every patient, from recruitment through to the end of trial and future follow up - a shift that requires a fundamental re-think of the role of the patient in the research journey. 

The Financial Times, in partnership with Medidata was honoured to host this exclusive virtual webinar. Watch this interactive panel discussion to explore what traditional and DCT sponsor representatives and clinical trial participants really think about DCTs. What should stay and what should go? How can sponsors, CROs, and service providers do a better job in optimising experiences for these two essential stakeholder groups? How can innovations be better executed to yield better results? 

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches and strategies to help win market share

Premier Digital Events supported by the world's best journalism

Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling events are chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice